Protamines and their role in pathogenesis of male infertility
Commentary

Protamines and their role in pathogenesis of male infertility

Shilpa Bisht, Priyanka Mathur, Rima Dada

Laboratory for Molecular Reproduction and Genetics, Department of Anatomy, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India

Correspondence to: Rima Dada. Laboratory for Molecular Reproduction and Genetics, Department of Anatomy, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India. Email: rima_dada@rediffmail.com.

Submitted May 10, 2016. Accepted for publication Jun 20, 2016.

doi: 10.21037/tcr.2016.06.24


Sperm DNA damage is the single largest cause of defective sperm function and may be the underlying cause of idiopathic male infertility. According to the WHO published data, male infertility contributes to about 45–50% cases of infertility (1). Male infertility is defined as a multifactorial syndrome affecting 1 out of every 20 men in the reproductive age group (2). Although extensive research has been done in the context of male infertility but the exact cause is still unknown (idiopathic) and is mainly attributed to genetic reasons (3). Decline in sperm function is believed to be the primary, single, and defined cause of male infertility, resulting in failed fertilization (4).

Mammalian sperm DNA shows six fold higher degree of compaction in comparison to the loose chromatin structure of somatic cells where the DNA is first packed into nucleosomes (5) and then into a solenoid (6). This hierarchical packaging increases the volume of chromatin in somatic cells because of the added volume of histones and central core of solenoid. However, such packaging is not possible in sperm chromatin as their nuclei do not possess the volume required for such level of DNA compaction.

Sperm nuclear genome is highly compacted and bound to sperm nuclear proteins called as protamines which are highly basic and the most abundant nuclear proteins in many species (including mammals) and act by extensive packaging of the sperm nuclear genome (7). The protamine gene family includes protamine 1 (PRM1), protamine 2 (PRM1) and transition protein 2 (TNP2) which together encompass a stretch of 13–15 kb of DNA on human chromosome 16p13.3. Protamines are highly basic nuclear proteins rich in arginine (40–70%) and cysteine (8–18%) which neutralise the charge on DNA and thus aids in its compaction. A single protamine gene is expressed in most mammals, but a second protamine gene is expressed in a few mammals, including mice and humans (8). PRM1 is encoded by a single-copy gene and the family of PRM2 proteins (PRM2, PRM3, and PRM4) are also encoded by a single gene. PRM1 is found in several species however, PRM2 is found in humans and few other mammals and data suggest a positive selection during evolution. Such a high level of condensation of the sperm nucleus aids in maintenance of the hydrodynamic shape, which aids both in sperm motility and its transit through the male and female reproductive tract and vital for maintenance of genomic integrity maintaining the epigenetic imprints (9). During later stages of spermiogenesis, majority of histones are replaced by transition proteins in the round spermatids which is then replaced by protamines i.e., protamine 1 (PRM1) and protamine 2 (PRM2) in the elongated spermatids and only 15% DNA retains the nucleosomal structure (10). The sperm genome is also partitioned into two compartments a peripheral histone bound compartment and a central compact crystalline toroid which is bound to protamines. Haploinsufficiency of either PRM1 or PRM2 (11) or abnormal PRM1/PRM2 protein ratio is associated with an increased risk of male factor infertility as this may result in improper compaction of sperm nuclear DNA and leaving the DNA highly vulnerable to environmental insults (12). Transgenic mice with altered expression of protamines present with infertility and have abnormal spermatozoa with several structural defects (13). Though there are several causes of DNA damage like oxidative stress, environmental pollutants, persistant organic pollutants, electromagnetic radiation, infections, inflammation, varicocele, persistence of nicks post spermiogenesis and defective packaging of sperm DNA makes the sperm more vulnerable to damage (14,15).

A noticeable number of case-control studies have been done which have shown that polymorphisms or mutations in protamine encoded genes results in conformational changes in the encoded proteins, changes in sperm chromatin structure and hence impaired spermatogenesis. Polymorphism in PRM1 (rs35576928, rs35262993, rs737008) and PRM2 (rs2070923, rs1646022) is associated with an increased risk of male infertility however, the elemental cause behind this is still unknown (16,17).

A recent meta-analysis by Jiang et al., 2015 and colleagues was done to establish the correlation between the 6 common single nucleotide polymorphisms i.e., rs35576928, rs35262993, rs737008 in PRM 1 and rs2070923, rs1646022 in PRM 2 and an increased risk to male infertility. This meta-analysis was based on 13 previously published case-control studies, including 7,350 cases and 6,167 controls (18). In this meta-analysis, the authors reported no significant association between rs737008 and male infertility under the four genotype models. (CA vs. CC, AA vs. CC, AA + CA vs. CC and AA vs. CA + CC) whereas subgroup analysis showed significant association between rs737008 polymorphism and male infertility in subgroups of population based under the dominant model (for AA + CA vs. CC: OR 0.75; 95% CI, 0.57–0.97; P=0.030), while no such correlation was observed for the other subgroups, such as the Asian and the Caucasian group. The authors found significant association between rs2301365 and an elevated risk of male infertility under the four genotype models (AA + CA vs. CC: OR 1.32; 95% CI, 1.08–1.60; P=0.006; for CA vs. CC: OR 1.27; 95% CI, 1.04–1.56; P=0.022; for AA vs. CC: OR 1.66; 95% CI, 1.07–2.58; P=0.024; for AA + CA vs. CC: OR 1.53; 95% CI, 1.00–2.36; P=0.052; for A vs. C: OR 1.28; 95% CI, 1.09–1.51; P=0.003). For rs1646022, no significant association was found between rs1646022 and male infertility risk under the four genotype models studied (GC vs. GG, CC vs. GG, CC + GC vs. GG and CC vs. GC + GG) but significant association was observed between rs1646022 and an increased risk of male infertility in subgroups of Asians (CC + GC vs. GG: OR 0.68; 95% CI, 0.48–0.97; P=0.032). Meta-analysis of other SNPs i.e., rs35576928, rs35262993 and rs2070923 did not find any association with an increased risk for male infertility.

An increase in sperm histone:protamine ratio is associated with poor chromatin compaction and thus, male factor infertility (19). Altered relative ratio of PRM1:PRM2 at the level of mRNA and protein also leads to male factor infertility (20). Perturbation in PRM1:PRM2 is associated with poor chromatin and hence an increased risk of male infertility as sperm requires a full complement of both the protamines to convey the male genome to the next generation (21). DNA damage in sperm is only partially repaired due to highly truncated DNA damage detection and repair mechanism (22). Jiang et al. documented the protective role of rs737008 polymorphism of PRM1 and rs1646022 polymorphism of PRM2 as protective factors against Asian infertility (16).

In the present meta-analysis, the authors have documented no association between rs35576928 and male infertility risk but He et al., have reported that PRM1 variant rs35576928 (p.R34S) is associated with severely defective spermatogenesis in the Chinese Han population (23). Cho et al., have documented that deficiency of PRM2 leads to disruption of PRM1:PRM2 ratio, sperm DNA damage and ultimately embryo cell death in mice (11). Thus, for maintenance of sperm DNA integrity optimal PRM1 and PRM2 ratios should be maintained as DNA repair mechanism are deficient in sperm and this is vital for birth of healthy offspring. Thus, a detailed history should be taken to exclude all possible causes of DNA damage and in idiopathic cases with loss of sperm DNA integrity, it is important to analyse expression levels of PRM1 and PRM2 and analysis of pathogenic variants in genes encoding for these proteins.


Acknowledgements

None.


Footnote

Provenance: This is a Guest Commentary commissioned by Section Editor Weijun Jiang, MS (Nanjing Normal University, Department of Reproductive and Genetics, Institute of Laboratory Medicine, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China).

Conflicts of Interest: The authors have no conflicts of interest to declare.

Comment on: Jiang W, Sun H, Zhang J, et al. Polymorphisms in Protamine 1 and Protamine 2 predict the risk of male infertility: a meta-analysis. Sci Rep 2015;5:15300.


References

  1. Infections, pregnancies, and infertility: perspectives on prevention. World Health Organization. Fertil Steril 1987;47:964-8. [Crossref] [PubMed]
  2. McLachlan RI, de Kretser DM. Male infertility: the case for continued research. Med J Aust 2001;174:116-7. [PubMed]
  3. Poongothai J, Gopenath TS, Manonayaki S. Genetics of human male infertility. Singapore Med J 2009;50:336-47. [PubMed]
  4. Hull MG, Glazener CM, Kelly NJ, et al. Population study of causes, treatment, and outcome of infertility. Br Med J (Clin Res Ed) 1985;291:1693-7. [Crossref] [PubMed]
  5. McGhee JD, Felsenfeld G. Nucleosome structure. Annu Rev Biochem 1980;49:1115-56. [Crossref] [PubMed]
  6. Finch JT, Klug A. Solenoidal model for superstructure in chromatin. Proc Natl Acad Sci U S A 1976;73:1897-901. [Crossref] [PubMed]
  7. Aoki VW, Carrell DT. Human protamines and the developing spermatid: their structure, function, expression and relationship with male infertility. Asian J Androl 2003;5:315-24. [PubMed]
  8. Corzett M, Mazrimas J, Balhorn R. Protamine 1: protamine 2 stoichiometry in the sperm of eutherian mammals. Mol Reprod Dev 2002;61:519-27. [Crossref] [PubMed]
  9. Oliva R. Protamines and male infertility. Hum Reprod Update 2006;12:417-35. [Crossref] [PubMed]
  10. Steger K, Pauls K, Klonisch T, et al. Expression of protamine-1 and -2 mRNA during human spermiogenesis. Mol Hum Reprod 2000;6:219-25. [Crossref] [PubMed]
  11. Cho C, Willis WD, Goulding EH, et al. Haploinsufficiency of protamine-1 or -2 causes infertility in mice. Nat Genet 2001;28:82-6. [Crossref] [PubMed]
  12. Carrell DT, Emery BR, Hammoud S. The aetiology of sperm protamine abnormalities and their potential impact on the sperm epigenome. Int J Androl 2008;31:537-45. [Crossref] [PubMed]
  13. Adham IM, Nayernia K, Burkhardt-Göttges E, et al. Teratozoospermia in mice lacking the transition protein 2 (Tnp2). Mol Hum Reprod 2001;7:513-20. [Crossref] [PubMed]
  14. Aitken RJ, Krausz C. Oxidative stress, DNA damage and the Y chromosome. Reproduction 2001;122:497-506. [Crossref] [PubMed]
  15. Aitken RJ, Smith TB, Jobling MS, et al. Oxidative stress and male reproductive health. Asian J Androl 2014;16:31-8. [Crossref] [PubMed]
  16. Jiang WJ, Zhang J, Xia XY, et al. Protamine gene polymorphisms and male infertility. Zhonghua Nan Ke Xue 2015;21:1134-7. [PubMed]
  17. Aoki VW, Christensen GL, Atkins JF, et al. Identification of novel polymorphisms in the nuclear protein genes and their relationship with human sperm protamine deficiency and severe male infertility. Fertil Steril 2006;86:1416-22. [Crossref] [PubMed]
  18. Jiang W, Sun H, Zhang J, et al. Polymorphisms in Protamine 1 and Protamine 2 predict the risk of male infertility: a meta-analysis. Sci Rep 2015;5:15300. [Crossref] [PubMed]
  19. Venkatesh S, Kumar R, Deka D, et al. Analysis of sperm nuclear protein gene polymorphisms and DNA integrity in infertile men. Syst Biol Reprod Med 2011;57:124-32. [Crossref] [PubMed]
  20. Steger K, Wilhelm J, Konrad L, et al. Both protamine-1 to protamine-2 mRNA ratio and Bcl2 mRNA content in testicular spermatids and ejaculated spermatozoa discriminate between fertile and infertile men. Hum Reprod 2008;23:11-6. [Crossref] [PubMed]
  21. Tanaka H, Miyagawa Y, Tsujimura A, et al. Single nucleotide polymorphisms in the protamine-1 and -2 genes of fertile and infertile human male populations. Mol Hum Reprod 2003;9:69-73. [Crossref] [PubMed]
  22. Mishra S, Kranthi V, Kumar R, et al. Oxidative Damage to Sperm DNA: Clinical Implications. Andrology 2014;3:116.
  23. He XJ, Ruan J, Du WD, et al. PRM1 variant rs35576928 (Arg>Ser) is associated with defective spermatogenesis in the Chinese Han population. Reprod Biomed Online 2012;25:627-34. [Crossref] [PubMed]
Cite this article as: Bisht S, Mathur P, Dada R. Protamines and their role in pathogenesis of male infertility. Transl Cancer Res 2016;5(3):324-326. doi: 10.21037/tcr.2016.06.24